SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
20-Jun-24 8:30 AM View: | Kymera Therapeutics, Inc. (KYMR) | 18-Jun-24 | Option Exercise | 14,413 | $2.08 | $29,979.00 | 2% 616.77K to 631.19K | |
02-Jan-24 5:43 PM View: | Kymera Therapeutics, Inc. (KYMR) | 02-Jan-24 | Option Exercise | 9,000 | $2.08 | $18,720.00 | 1% 606.57K to 615.57K | |
06-Nov-23 6:00 PM View: | Kymera Therapeutics, Inc. (KYMR) | 03-Nov-23 | Option Exercise | 20,000 | $2.08 | $41,600.00 | 3% 586.57K to 606.57K | |
08-Aug-23 4:30 PM View: | Kymera Therapeutics, Inc. (KYMR) | 08-Aug-23 | Option Exercise | 12,000 | $2.08 | $24,960.00 | 2% 574.57K to 586.57K | |
08-Dec-22 6:11 PM View: | Kymera Therapeutics, Inc. (KYMR) | 08-Dec-22 | Option Exercise | 10,000 | $2.08 | $20,800.00 | 2% 563.7K to 573.7K | |
17-Oct-22 8:09 PM View: | Kymera Therapeutics, Inc. (KYMR) | 17-Oct-22 | Option Exercise | 59,732 | $2.08 | $124,243.00 | 12% 502.2K to 561.93K | |
03-May-22 7:27 PM View: | Kymera Therapeutics, Inc. (KYMR) | 03-May-22 | Option Exercise | 20,000 | $2.08 | $41,600.00 | 4% 482.2K to 502.2K | |
14-Jan-22 5:30 PM View: | Kymera Therapeutics, Inc. (KYMR) | 14-Jan-22 | Option Exercise | 10,000 | $2.08 | $20,800.00 | 2% 472.2K to 482.2K | |
12-Jan-22 7:30 PM View: | Kymera Therapeutics, Inc. (KYMR) | 12-Jan-22 | Option Exercise | 8,612 | $2.08 | $17,913.00 | 2% 472.2K to 480.81K | |
12-Jan-22 7:30 PM View: | Kymera Therapeutics, Inc. (KYMR) | 12-Jan-22 | Planned Option Sale | 8,612 | $52.08 | $448,551.00 | (2%) 480.81K to 472.2K | |
12-Jan-22 7:30 PM View: | Kymera Therapeutics, Inc. (KYMR) | 11-Jan-22 | Option Exercise | 16,923 | $2.08 | $35,199.80 | 4% 472.2K to 489.12K | |
12-Jan-22 7:30 PM View: | Kymera Therapeutics, Inc. (KYMR) | 11-Jan-22 | Planned Option Sale | 16,923 | $54.00 | $913,795.00 | (3%) 489.12K to 472.2K | |
12-Jan-22 7:30 PM View: | Kymera Therapeutics, Inc. (KYMR) | 10-Jan-22 | Option Exercise | 22,465 | $2.08 | $46,727.20 | 5% 472.2K to 494.66K | |
12-Jan-22 7:30 PM View: | Kymera Therapeutics, Inc. (KYMR) | 10-Jan-22 | Market Option Sale (Planned) | 22,465 | $53.26 | $1,196,400.00 | (5%) 494.66K to 472.2K | |
16-Dec-21 4:49 PM View: | Kymera Therapeutics, Inc. (KYMR) | 16-Dec-21 | Option Exercise | 8,000 | $2.08 | $16,640.00 | 2% 464.2K to 472.2K | |
12-Oct-21 4:30 PM View: | Kymera Therapeutics, Inc. (KYMR) | 11-Oct-21 | Option Exercise | 6,456 | $2.08 | $13,428.50 | 1% 464.2K to 470.65K | |
12-Oct-21 4:30 PM View: | Kymera Therapeutics, Inc. (KYMR) | 11-Oct-21 | Market Option Sale (Planned) | 6,456 | $53.69 | $346,590.00 | (1%) 470.65K to 464.2K | |
12-Oct-21 4:30 PM View: | Kymera Therapeutics, Inc. (KYMR) | 08-Oct-21 | Option Exercise | 41,544 | $2.08 | $86,411.50 | 9% 464.2K to 505.74K | |
12-Oct-21 4:30 PM View: | Kymera Therapeutics, Inc. (KYMR) | 08-Oct-21 | Market Option Sale (Planned) | 41,544 | $56.76 | $2,357,950.00 | (8%) 505.74K to 464.2K | |
19-Aug-21 4:30 PM View: | Kymera Therapeutics, Inc. (KYMR) | 19-Aug-21 | Option Exercise | 12,000 | $2.08 | $24,960.00 | 3% 452.2K to 464.2K | |
05-Aug-21 4:14 PM View: | Kymera Therapeutics, Inc. (KYMR) | 04-Aug-21 | Option Exercise | 1,037 | $2.08 | $2,156.96 | < 1% 452.2K to 453.24K | |
05-Aug-21 4:14 PM View: | Kymera Therapeutics, Inc. (KYMR) | 04-Aug-21 | Market Option Sale (Planned) | 1,037 | $60.03 | $62,252.90 | (< 1%) 453.24K to 452.2K | |
05-Aug-21 4:14 PM View: | Kymera Therapeutics, Inc. (KYMR) | 03-Aug-21 | Option Exercise | 5,669 | $2.08 | $11,791.50 | 1% 452.2K to 457.87K | |
05-Aug-21 4:14 PM View: | Kymera Therapeutics, Inc. (KYMR) | 03-Aug-21 | Market Option Sale (Planned) | 5,669 | $60.07 | $340,533.00 | (1%) 457.87K to 452.2K | |
02-Aug-21 5:53 PM View: | Kymera Therapeutics, Inc. (KYMR) | 02-Aug-21 | Option Exercise | 23,456 | $2.08 | $48,788.50 | 5% 452.2K to 475.65K | |
02-Aug-21 5:53 PM View: | Kymera Therapeutics, Inc. (KYMR) | 02-Aug-21 | Market Option Sale (Planned) | 23,456 | $60.30 | $1,414,400.00 | (5%) 475.65K to 452.2K | |
02-Aug-21 5:53 PM View: | Kymera Therapeutics, Inc. (KYMR) | 30-Jul-21 | Option Exercise | 6,279 | $2.08 | $13,060.30 | 1% 452.2K to 458.48K | |
02-Aug-21 5:53 PM View: | Kymera Therapeutics, Inc. (KYMR) | 30-Jul-21 | Market Option Sale (Planned) | 6,279 | $60.07 | $377,167.00 | (1%) 458.48K to 452.2K | |
02-Aug-21 5:53 PM View: | Kymera Therapeutics, Inc. (KYMR) | 29-Jul-21 | Option Exercise | 680 | $2.08 | $1,414.40 | < 1% 452.2K to 452.88K | |
02-Aug-21 5:53 PM View: | Kymera Therapeutics, Inc. (KYMR) | 29-Jul-21 | Market Option Sale (Planned) | 680 | $60.00 | $40,800.00 | (< 1%) 452.88K to 452.2K | |
28-Jul-21 4:57 PM View: | Kymera Therapeutics, Inc. (KYMR) | 28-Jul-21 | Option Exercise | 3,864 | $2.08 | $8,037.12 | < 1% 452.2K to 456.06K | |
28-Jul-21 4:57 PM View: | Kymera Therapeutics, Inc. (KYMR) | 28-Jul-21 | Market Option Sale (Planned) | 3,864 | $60.15 | $232,410.00 | (< 1%) 456.06K to 452.2K | |
28-Jul-21 4:57 PM View: | Kymera Therapeutics, Inc. (KYMR) | 26-Jul-21 | Option Exercise | 9,015 | $2.08 | $18,751.20 | 2% 452.2K to 461.21K | |
28-Jul-21 4:57 PM View: | Kymera Therapeutics, Inc. (KYMR) | 26-Jul-21 | Market Option Sale (Planned) | 9,015 | $60.15 | $542,237.00 | (2%) 461.21K to 452.2K | |
09-Jul-21 4:30 PM View: | Kymera Therapeutics, Inc. (KYMR) | 08-Jul-21 | Option Exercise | 48,000 | $2.08 | $99,840.00 | 11% 452.2K to 500.2K | |
09-Jul-21 4:30 PM View: | Kymera Therapeutics, Inc. (KYMR) | 08-Jul-21 | Market Option Sale (Planned) | 48,000 | $49.70 | $2,385,630.00 | (10%) 500.2K to 452.2K | |
14-Jun-21 5:57 PM View: | Kymera Therapeutics, Inc. (KYMR) | 14-Jun-21 | Option Exercise | 40,000 | $2.08 | $83,200.00 | 10% 412.2K to 452.2K | |
11-Jun-21 4:15 PM View: | Kymera Therapeutics, Inc. (KYMR) | 10-Jun-21 | Option Exercise | 23,009 | $2.08 | $47,858.70 | 6% 412.2K to 435.21K | |
11-Jun-21 4:15 PM View: | Kymera Therapeutics, Inc. (KYMR) | 10-Jun-21 | Market Option Sale (Planned) | 23,009 | $51.38 | $1,182,110.00 | (5%) 435.21K to 412.2K | |
09-Jun-21 5:54 PM View: | Kymera Therapeutics, Inc. (KYMR) | 09-Jun-21 | Option Exercise | 5,752 | $2.08 | $11,964.20 | 1% 412.2K to 417.95K | |
09-Jun-21 5:54 PM View: | Kymera Therapeutics, Inc. (KYMR) | 09-Jun-21 | Market Option Sale (Planned) | 5,752 | $50.02 | $287,721.00 | (1%) 417.95K to 412.2K | |
09-Jun-21 5:54 PM View: | Kymera Therapeutics, Inc. (KYMR) | 08-Jun-21 | Option Exercise | 270 | $2.08 | $561.60 | < 1% 412.2K to 412.47K | |
09-Jun-21 5:54 PM View: | Kymera Therapeutics, Inc. (KYMR) | 08-Jun-21 | Market Option Sale (Planned) | 270 | $50.00 | $13,500.00 | (< 1%) 412.47K to 412.2K | |
09-Jun-21 5:54 PM View: | Kymera Therapeutics, Inc. (KYMR) | 07-Jun-21 | Option Exercise | 12,724 | $2.08 | $26,465.90 | 3% 412.2K to 424.92K | |
09-Jun-21 5:54 PM View: | Kymera Therapeutics, Inc. (KYMR) | 07-Jun-21 | Market Option Sale (Planned) | 12,724 | $50.14 | $638,040.00 | (3%) 424.92K to 412.2K | |
19-May-21 5:56 PM View: | Kymera Therapeutics, Inc. (KYMR) | 19-May-21 | Option Exercise | 15,000 | $2.08 | $31,200.00 | 4% 397.2K to 412.2K | |
14-May-21 5:20 PM View: | Kymera Therapeutics, Inc. (KYMR) | 12-May-21 | Option Exercise | 8,245 | $2.08 | $17,149.60 | 2% 397.2K to 405.44K | |
14-May-21 5:20 PM View: | Kymera Therapeutics, Inc. (KYMR) | 12-May-21 | Market Option Sale (Planned) | 8,245 | $50.05 | $412,677.00 | (2%) 405.44K to 397.2K | |
26-Apr-21 5:15 PM View: | Kymera Therapeutics, Inc. (KYMR) | 26-Apr-21 | Option Exercise | 2,768 | $2.08 | $5,757.44 | < 1% 397.2K to 399.97K | |
26-Apr-21 5:15 PM View: | Kymera Therapeutics, Inc. (KYMR) | 26-Apr-21 | Market Option Sale (Planned) | 2,768 | $40.18 | $111,229.00 | (< 1%) 399.97K to 397.2K |